Kinshasa, DR Congo / RankWire.AI / – The Democratic Republic of the Congo health authorities have confirmed that the total number of infections in the country’s ongoing Ebola outbreak has now reached 3,075, with Congo Ebola cases crossing 3,000 amid a significant acceleration in transmission. Data from the health ministry show that the epidemic has resulted in 1,354 deaths and 556 recoveries. Currently, 755 patients are receiving treatment in hospitals and specialized isolation units. Declared on May 15, this outbreak is now the fastest-growing Ebola epidemic on record, adding 1,000 new cases in less than two weeks after surpassing the 2,000-case mark on July 15.
The surge is driven by the Bundibugyo strain of the Ebola virus, a rare variant for which no approved vaccines or specific antiviral treatments currently exist. On May 17, the World Health Organization’s leadership declared the outbreak in the Democratic Republic of the Congo and neighboring Uganda a public health emergency of international concern. International health officials have assessed the risk of cross-border transmission as high due to population movements and ongoing conflict in affected areas. Epidemiological data indicate that nearly 90 percent of all confirmed infections are concentrated in the northeastern province of Ituri, a region bordering South Sudan and Uganda.
During a recent briefing on the emergency response, Dr. Jean Kaseya, Director General of the Africa Centres for Disease Control and Prevention, highlighted the critical challenges faced by frontline healthcare workers. He pointed out that many patients are dying because of shortages of essential therapeutics, protective gear, and international financial aid. The current outbreak has resulted in fatalities at a rate faster than the West Africa epidemic from 2013 to 2016, which claimed over 11,000 lives in two years. While previous outbreaks took about eight months to reach 1,000 deaths, the Bundibugyo strain’s outbreak surpassed that milestone in just ten weeks.
Features and Obstacles of the Bundibugyo Strain
Efforts to combat the outbreak across multiple regional treatment centers have faced severe disruptions caused by ongoing strikes by local healthcare personnel demanding unpaid wages. DRC health officials stated that although diagnostic capacity has improved and testing has expanded, administrative delays and logistical issues hinder containment. Staff at hospitals in eastern provinces continue to demand immediate government disbursements for risk allowances and operational funding. Public health officials warn that persistent strikes inside isolation facilities could further accelerate community transmission in rural areas nearby.
In the absence of targeted medical countermeasures, international research institutions are fast-tracking clinical trials for experimental vaccines. Researchers at Oxford University have announced that a first group of human volunteers has received a candidate vaccine specifically designed to neutralize the Bundibugyo strain. Meanwhile, neighboring East African countries have increased border screening measures and distributed personal protective equipment at transit hubs. These governments are working with international health partners to prevent secondary outbreaks within major urban transit centers.
International Emergency Declared in Central Africa
Epidemiological models reviewed by global health agencies project that the epidemic could persist for several more months before peaking. International humanitarian organizations continue to organize specialized medical airlifts, delivering diagnostic reagents, protective gear, and hydration supplies to regional hospitals. Public health leaders emphasize that establishing reliable supply chains to remote treatment units is crucial for reducing fatalities. Community outreach initiatives are being expanded to improve contact tracing and address public skepticism about medical isolation efforts.
Global health organizations stress that controlling the outbreak requires ongoing international financial support and rapid deployment of medical supplies. The emergency response plan prioritizes strengthening local healthcare capacity, ensuring health worker compensation, and deploying experimental vaccines under emergency use protocols. Authorities believe that quick deployment of therapeutics alongside rigorous contact tracing remains the most effective way to curb regional transmission and protect vulnerable populations across Africa.